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1. Introduction 
Within the last few years, evidence has accumulated 
that several plant viral RNA’s possess a tRNA-like 
structure at their 3’ end, since they can be charged 
with an amino acid, and since they are recognized by 
a series of enzymes specific of tRNAs [l-9]. Thus, 
the RNA of Turnip Yellow Mosaic Virus (TYMV) and 
of two other tymoviruses can be aminoacylated with 
valine [ 1,2,7], and the RNA of the members of the 
bromovirus group and that of Cucumber Mosaic Virus 
by tyrosine (8 and R. J. Kohl and T. C. Hall, personal 
communication). 
It has been reported that TMV RNA can accept 
histidine [4,9], and moreover that the histidyl-RNA 
can form a ternary complex with wheat embryo 
elongation factor EF-1 and GTP [4]. Further, the 
sequence of the pentanucleotide at the 3’ end of the 
viral RNA of 2 X lo6 daltons [lo] is known to be 
-GCCCA [ 111. It is interesting to note that only few 
tRNAs contain a cytidine residue in the fourth 
position from the 3’ end [ 121. Those which are 
known are acceptor only of histidine or of proline. 
Because of the tRNA-like properties of this viral 
RNA, and since it contains the 3’ terminal sequence 
--CCA common to all tRNAs, we have investigated 
whether it could also be a substrate of the tRNA 
nucleotidyltransferase (CCA-enzyme), the enzyme 
capable of adding back CCA to tRNA deprived of 
this 3’ terminal sequence. 
Our conclusion is that under conditions wherein 
the CCA-enzyme ‘repairs’ tRNAs, it also adequately 
‘repairs’ TMV RNA, adding back the -CCA sequence 
to the RNA from which the 3’ terminal trinucleotide 
has been previously rem&d. As this work was 
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nearing completion, we learned that similar results 
had been obtained by S. Litvak (personal communi- 
cation). 
2. Materials 
The following strains of TMV: Vulgare, U, , HRG 
and Dahlmensis were kindly provided by Dr. S. J. 
Morris (Heidelberg), and their viral RNA’s extracted 
as described by Gierer and Schramm [13]. Highly 
purified E. coli tRNA nucleotidyltransferase was a 
kind gift of Dr. D. Car6 We are grateful to Dr. 
C. Gualerzi for a sample of rat liver high speed super- 
natant devoid of tRNAH”. Snake venom phosphodi- 
esterase was from Worthington and Ribonuclease T1 
from Sankyo. [3H]ATP (22.7 Ci/mmole) and [14C] - 
CTP (308 mCi/mmole) were from Schwartz Bio- 
Research, and [’ 4 C] histidine (45 mCi/mmole) from 
the Commissariat Q 1’Energie Atomique (Saclay). 
3. Methods 
3.1. Esterification of histidine to TMV RNA 
The incubation mixture contained in a final 
volume of 0.2 ml: 10 pmoles Tris-HCl pH 7.4, 
2 pmoles MgClz, 2 pmoles dithiothreitol, 0.4 pmole 
ATP, 150 pg of rat liver high speed supernatant, 
150 pg of TMV RNA and 0.01 pmole of [ l4 C] his- 
tidine. After incubation for 20 min at 37’C, 10% cold 
trichloroacetic acid was added, the precipitate col- 
lected on Millipore filters and counted in Bray’s 
solution. 
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3.2. Treatment of TMVRNA with snake venom 
phosphodiesterase 
The conditions of incubation were analogous to 
those described by Miller et al. for tRNA [ 141. In a 
final volume of 0.1 ml containing 10 pmoles Tris- 
HCl pH 7.7, 1 I.tmole Mg acetate and 30 fig of snake 
venom phosphodiesterase, 200 c(g of TMV RNA 
were added and incubation performed for 15 min at 
37°C. The reaction was stopped by addition of an 
equal volume of water-saturated phenol, and the 
RNA’s recovered from the aqueous phase by ethanol 
precipitation. 
3.3. Incubation with the CCA-enzyme 
The experimental conditions were similar to those 
of Carre et al. [ 151. The incubation was performed in 
a final volume of 0.05 ml containing 2.5 I.tmoles 
Tris-acetate pH 8.3, 0.5 pmole Mg acetate, 0.5 pmole 
DTT, 0.25 nmole CTP, 2.5 nmoles [3H]ATP (1.25 Ci/ 
mmole), 75 clg of TMV RNA previously treated with 
or without snake venom phosphodiesterase, and 
l-2 pg of CCA-enzyme. Incubation was for 1 to 3 hr 
at 37°C. The reaction was stopped by addition of 
cold 1% trichloroacetic acid. The precipitates were 
collected on Millipore filters and their radioactivity 
determined in the presence of Bray’s solution. 
In experiments where labelled CTP was also used, 
0.8 nmoles [14C]CTP replaced the unlabelled CTP 
and a preincubation step was performed in the 
presence of all the other ingredients except ATP for 
20 mm at 37°C. [3H]ATP was then’added at the con- 
centrations indicated and incubation pursued 20 min 
more. The reaction was stopped by addition of cold 
1% trichloroacetic acid, and the radioactivity in the 
precipitates determined as above. 
For preparative purposes the incubation mixtures 
were scaled up and the incubation performed as above, 
except that unlabelled CTP (2.5 nmoles/0.5 ml incu- 
bation mixture) was used and that the specific 
activity of the [3 H] ATP was 750 mCi/mmole. The 
reaction was stopped by addition of phenol and the 
labelled product was recovered by ethanol precipita- 
tion. It was then purified by filtration over a Sephadex 
G-100 (0.9 X 30 cm) column equilibrated with 
0.01 M sodium cacodylate pH 6.0,O. 1 M NaCl and 
0.02 M EDTA. The material eluting in the void volume 
was collected and concentrated by ethanol precipita- 
tion. 
3.4. DEAE-cellulose chromatography of the RNase 
T1 digests of L3H]AMPRNA of TMV 
The incubation conditions and the procedure for 
the analysis of the labelled oligonucleotide by DEAE- 
cellulose chromatography were as already described 
[2]. TMV RNA (200 pg containing 30 pmoles of 
[3H]AMP) were incubated with 50 units of RNase 
Tr in a total volume of 300 1.t1 containing 15 pmoles 
Tris-HCl pH 7.7 and 6 fimoles EDTA. After 15 min 
at 37”C, the mixture was adjusted to 0.05 M 
ammonium acetate pH 5.5 and 7 M urea, and loaded 
on a DEAE-cellulose column (15 X 0.9 cm) equi- 
librated in the same solution. After washing of the 
column, a linear (0.05-0.6 M) ammonium acetate 
gradient pH 5.5 in 7 M urea was applied (total 
volume = 150 ml). One ml fractions were collected 
and counted in the presence of 10 ml Triton-fluor. 
4. Results and discussion 
4.1. AMP incorporation into various strains of TMV 
RNA 
It has been reported that the level of amino- 
acylation using a yeast extract as source of histidyl- 
tRNA synthetase varies from one strain of TMV RNA 
to another; further, it has been proposed that the 
tRNA-like structure of the TMV RNA’s which are 
poorly aminoacylated might be embedded in the 
viral genome and thus not be readily accessible to 
the histidyl-tRNA synthetase, since preheating of 
Table 1 
Comparison of histidine and AMP incorporation into various 
strains of TMV RNA 
Strain 
pmoles histidine 
bound per pmole 
untreated RNA 
pmoles AMP bound 
per pmole phospho- 
diesterase-treated 
RNA 
u2 0.25 0.30 
Vulgare 0.24 0.40 
HRG 0.24 0.18 
Dahlmensis 0.04 0.19 
The conditions were given under Methods. A level of 
0.05 pmole AMP was bound per pmole of untreated TMV 
RNA. 
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such RNAs leads to an increase in histidine accept- 
ance [16]. 
We have therefore investigated whether a similar 
difference between strains could be detected with the 
CCA-enzyme. Having confirmed that incorporation 
of AMP with the CCA-enzyme was negligeable when 
untreated TMV RNA was used as substrate [ 171, the 
viral genome was treated with snake venom phos- 
phodiesterase prior to incubation with the CCA- 
enzyme. The results presented in table 1 show that 
there was no direct correlation between the level of 
AMP incorporation and aminoacylation; they confirm 
the fact that with a rat liver extract also, however, the 
amount of histidine bound to the RNA depends on 
the TMV strain used. 
4.2. Effect of CMP incorporation on the incorporation 
of AMP into TMV RNA 
In order to verify whether the incorporation of 
AMP was dependent on the incorporation of CMP, 
phosphodiesterase-treated TMV RNA was preincubat- 
ed in the presence or absence of CTP, after which 
[3H]ATP was added and incubation pursued. The 
data presented in fig. 1 show that indeed incorpora- 
Fig. 1. Effect of CMP incorporation on AMP incorporation 
into TMV RNA (Vulgare). Conditions were as described 
under Methods, control experiments being performed in the 
absence of CTP. The specific activity of the [3H]ATP was 
decreased for high concentrations of the nucleotide: it varied 
between 2 and 0.4 Ci/mmolc for concentrations between 0.01 
and 0.4 mM respectively. It was previously verified by 
kinetic studies that in the conditions of CTP concentration 
used here, incorporation of CMP reached a plateau level after 
20 min of incubation at 37°C. This lcvcl correspond lo 
0.8 pmolc of CMP/pmolc of RNA, or 40% incorporation if it 
is assumed that two CMP rcsidurs are incorporated per RNA 
molecule. 
tion of AMP was favored by preincubation with CTP. 
The AMP incorporated in the absence of CTP may 
reflect insufficient treatment of the RNA with snake 
venom phosphodiesterase that would have led to RNA 
molecules deprived only of the terminal adenosine. 
Fig. 2 presents the results of an experiment in 
6 
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Fig. 2. Ratio of CMP to AMP incorporation into TMV RNA 
(Vulgare) as a function of ATP concentration. Experimental 
conditions were as indicated under Methods, and the 
specific activities of the [3H]ATP as given in the legend of 
fig. 1. 
which incorporation of [’ 4 C] CMP and [3 H] AMP 
were measured with increasing [3H]ATP concentra- 
tions. At a concentration of 1 X 6 X 10m5 M CTP, 
2 X 10e4 M ATP is required to reach the stable value 
of two CMP incorporated per AMP, as also reported 
by CarrC et al. [ 151 for tRNA’s. Our results therefore 
suggest hat incorporation into phosphodiesterase- 
treated TMV RNA proceeds by the successive 
addition of two CMP and one AMP residues into the 
3’ terminus of the viral genome. 
4.3. RNase Tl digests of TMVRNA bearing [3H]AMP 
If indeed the CCA-enzyme incorporated CMP and 
AMP into the 3’ end of the viral RNA, then after 
RNase Tr digestion, analysis by DEAE-cellulose 
chromatography should reveal a tetranucleotide cor- 
responding to the 3’ terminus of the RNA, since TMV 
RNA is terminated by the sequence -GCCCA [ 111. 
Phosphodiesterase-treated TMV RNA was incubat- 
ed with the CCA-enzyme as indicated in Methods, 
using unlabelled CTP and [3H]ATP. After RNasc T, 
digestion, the oligonucleotides were separated by 
DEAE-cellulose chromatography. The elution profile 
of the labelled oligonucleotides is presented in fig. 3. 
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Fig. 3. Analysis of the Rnase Tt digests of TMV RNA (U,) 
bearing [3 H] AMP. The incubation condition and the 
analytical procedure were as described under Methods. 
Only a single peak is detected, whose position on the 
column is in accordance with that of a tetranucleo- 
tide, since it coincides with that of TMV histidyl-RNA 
treated under similar conditions [ 161, and since it 
elutes before TYMV [3 H] valyl-RNA or TYMV 
[3 HI AMP-RNA obtained by a similar treatment 
which yields a pentanucleotide ([2] and A. Prochiantz 
et al., in preparation). 
These results therefore indicate that the CCA- 
enzyme has added back CMP and AMP into the 3’ 
terminus of the phosphodiesterase-treated TMV RNA. 
Because tRNA nucleotidyltransferase has been 
found in all cells examined to date, it is undoubtedly 
present in the host cells of TMV. Consequently, since 
TMV RNA is a substrate of the tRNA nucleotidyl 
transferase, one can imagine that this enzyme may 
play a role in the synthesis of the viral RNA by 
terminal addition of AMP and possibly CMP after 
replication. 
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